MedEquities Realty Trust Inc (NYSE:MRT) – Research analysts at FBR & Co raised their FY2016 EPS estimates for shares of MedEquities Realty Trust in a note issued to investors on Thursday. FBR & Co analyst Maher. B now anticipates that the firm will post earnings per share of $1.11 for the year, up from their prior forecast of $1.08. FBR & Co currently has a “Buy” rating on the stock. FBR & Co also issued estimates for MedEquities Realty Trust’s Q4 2016 earnings at $0.26 EPS, FY2017 earnings at $1.26 EPS, Q2 2018 earnings at $0.36 EPS, Q3 2018 earnings at $0.36 EPS and FY2018 earnings at $1.39 EPS.

A number of other equities research analysts also recently issued reports on the company. Raymond James Financial Inc. assumed coverage on MedEquities Realty Trust in a research report on Monday, October 24th. They set an “outperform” rating and a $13.00 price target for the company. RBC Capital Markets assumed coverage on MedEquities Realty Trust in a research report on Monday, October 24th. They issued an “outperform” rating and a $13.00 target price for the company. JMP Securities assumed coverage on MedEquities Realty Trust in a research report on Monday, October 24th. They issued an “outperform” rating and a $13.00 target price for the company. Royal Bank Of Canada assumed coverage on MedEquities Realty Trust in a research report on Monday, October 24th. They issued an “outperform” rating and a $13.00 target price for the company. Finally, JPMorgan Chase & Co. assumed coverage on MedEquities Realty Trust in a research report on Monday, October 24th. They issued a “neutral” rating and a $13.00 target price for the company. Two research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $13.00.

Earnings History and Estimates for MedEquities Realty Trust (NYSE:MRT)

Shares of MedEquities Realty Trust (NYSE:MRT) opened at 10.57 on Friday. The firm has a market cap of $118.91 million and a price-to-earnings ratio of 251.67. The stock’s 50 day moving average price is $11.49 and its 200 day moving average price is $11.49. MedEquities Realty Trust has a 12 month low of $10.28 and a 12 month high of $12.05.

In other MedEquities Realty Trust news, CAO David L. Travis purchased 2,500 shares of the business’s stock in a transaction that occurred on Tuesday, October 4th. The shares were acquired at an average price of $12.00 per share, for a total transaction of $30,000.00. Following the completion of the purchase, the chief accounting officer now owns 15,934 shares in the company, valued at approximately $191,208. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Randy L. Churchey purchased 15,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 4th. The stock was acquired at an average price of $12.00 per share, for a total transaction of $180,000.00. Following the purchase, the director now owns 39,720 shares of the company’s stock, valued at approximately $476,640. The disclosure for this purchase can be found here.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in MRT. SG Americas Securities LLC acquired a new position in MedEquities Realty Trust during the third quarter valued at approximately $238,000. DIAM Co. Ltd. acquired a new position in MedEquities Realty Trust during the third quarter valued at approximately $377,000. Moody Lynn & Lieberson LLC acquired a new position in MedEquities Realty Trust during the third quarter valued at approximately $811,000. Monashee Investment Management LLC acquired a new position in MedEquities Realty Trust during the third quarter valued at approximately $881,000. Finally, Emerald Acquisition Ltd. acquired a new position in MedEquities Realty Trust during the third quarter valued at approximately $1,552,000.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust, Inc is a self-managed and self-administered company. The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company owns, acquires and finances healthcare-related properties. The Company primarily invests in various types of healthcare properties, such as acute care hospitals, short stay surgical and specialty hospitals (such as those focusing on orthopedic, heart, and other dedicated surgeries and specialty procedures), dedicated specialty hospitals (such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care), skilled nursing facilities, physician group practice clinics, diagnostic facilities, outpatient surgery centers and facilities that support these services, such as medical office buildings.

5 Day Chart for NYSE:MRT

Receive News & Stock Ratings for MedEquities Realty Trust Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust Inc and related stocks with our FREE daily email newsletter.